Breaking News Instant updates and real-time market news.

SNN

Smith & Nephew

$36.13

(0.00%)

09:33
12/11/17
12/11
09:33
12/11/17
09:33

Smith & Nephew downgraded to Equal Weight from Overweight at Morgan Stanley

SNN Smith & Nephew
$36.13

(0.00%)

03/21/17
03/21/17
UPGRADE
Target $36

Buy
Wright Medical upgraded on increased likelihood of a takeout at Northcoast
As previously reported, Northcoast upgraded Wright Medical (WMGI) to Buy from Neutral with a $36 price target. Analyst David Kaiser said he has been slow to appreciate Wright's competitive advantages in the extremity market and believes a takeout is increasingly likely in 2017. The analyst attended last week's American Academy of Orthopedic Surgeons annual meeting and said multiple private industry contacts told him there is increased speculation in the market about one of the four major joint replacement manufacturers acquiring Wright Medical soon. Kaiser believes Smith & Nephew (SNN) is the most logical acquirer given it has virtually no presence in the extremity market, has a very strong balance sheet, and a clear strategy to shift its business mix to faster-growing areas.
10/11/17
ADAM
10/11/17
INITIATION
Target $42
ADAM
Buy
Smith & Nephew initiated with a Buy at Canaccord
Canaccord analyst Kyle rose initiated Smith & Nephew with a Buy as he believes its broad product portfolio provides a stronger foundation from which the company can realize accelerating top-line growth. He said its recent restructuring has positioned it to focus on commercial execution and operating leverage. Rose has a $42 price target on Smith & Nephew shares.

TODAY'S FREE FLY STORIES

VLRX

Valeritas

$1.52

-0.05 (-3.18%)

07:06
05/23/18
05/23
07:06
05/23/18
07:06
Hot Stocks
Valeritas' V-Go device shows benefits in type 2 diabetes »

Valeritas announced data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

$70.40

-1.35 (-1.88%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Hot Stocks
Cubic's CTS unit awarded contract from SRTA in Atlanta »

Cubic Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

TGT

Target

$75.42

-1.44 (-1.87%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Technical Analysis
Technical Take: Target falls sharply after earnings miss »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

REX

REX American Resources

$76.62

-0.5 (-0.65%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Earnings
REX American Resources reports Q1 EPS $1.45 vs. 69c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

ALKS

Alkermes

$45.58

0.35 (0.77%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Hot Stocks
Alkermes to present data on depression, schizophrenia portfolios at ASCP »

Alkermes announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    Jan

KOOL

Cesca Therapeutics

$0.53

0.0307 (6.14%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Initiation
Cesca Therapeutics initiated  »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCI

Navigant Consulting

$24.00

-0.19 (-0.79%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Hot Stocks
Navigant Consulting, Lumere announce collaboration to reduce clinical variation »

Navigant Consulting and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ACRX

AcelRx

$2.95

0.05 (1.72%)

07:03
05/23/18
05/23
07:03
05/23/18
07:03
Hot Stocks
Three Arch's shares of AcelRx stock acquired in deal led by Leerink Revelation »

AcelRx Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:02
05/23/18
05/23
07:02
05/23/18
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 5/18 MBA Mortgage…

ANTM

Anthem

$234.12

0.52 (0.22%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Hot Stocks
Anthem to acquire Aspire Health, financial terms not disclosed »

Anthem announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MINE

Minerco Resources

$0.00

(0.00%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Hot Stocks
Minerco acquires controlling interest in Priwen Systems »

Minerco announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XCRA

Xcerra

$14.01

0.31 (2.26%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Earnings
Xcerra reports Q3 non-GAAP EPS 24c, consensus 20c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SO

Southern Company

$43.55

0.13 (0.30%)

07:01
05/23/18
05/23
07:01
05/23/18
07:01
Hot Stocks
Southern Power to sell minority stake in solar portfolio for $1.175B to GAFG »

Southern Power, a U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPX

S&P 500

$0.00

(0.00%)

07:00
05/23/18
05/23
07:00
05/23/18
07:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$33.33

-0.02 (-0.06%)

07:00
05/23/18
05/23
07:00
05/23/18
07:00
Hot Stocks
Aecom awarded 15-year $3.1B U.S. Air Force contract »

AECOM's wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$177.66

0.08 (0.05%)

, CVS

CVS Health

$65.59

0.09 (0.14%)

06:58
05/23/18
05/23
06:58
05/23/18
06:58
Recommendations
Aetna, CVS Health analyst commentary  »

Aetna risk/reward…

AET

Aetna

$177.66

0.08 (0.05%)

CVS

CVS Health

$65.59

0.09 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

FTR

Frontier Communications

$9.55

-0.06 (-0.62%)

06:58
05/23/18
05/23
06:58
05/23/18
06:58
Periodicals
Frontier in talks with bondholders after failed asset auction, Bloomberg reports »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$39.46

-4.14 (-9.50%)

06:55
05/23/18
05/23
06:55
05/23/18
06:55
Recommendations
Toll Brothers analyst commentary  »

Toll Brothers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$183.81

-0.67 (-0.36%)

06:53
05/23/18
05/23
06:53
05/23/18
06:53
Periodicals
Facebook's upper ranks never seem to leave company, Recode reports »

Facebook's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

TIF

Tiffany

$102.26

-0.96 (-0.93%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Hot Stocks
Breaking Hot Stocks news story on Tiffany »

Tiffany up 7.8% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

REGN

Regeneron

$294.72

-1.86 (-0.63%)

, SNY

Sanofi

$38.93

0.15 (0.39%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Recommendations
Regeneron, Sanofi analyst commentary  »

Regeneron product…

REGN

Regeneron

$294.72

-1.86 (-0.63%)

SNY

Sanofi

$38.93

0.15 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Aug

  • 20

    Oct

  • 28

    Jan

MRK

Merck

$58.46

-0.1 (-0.17%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Hot Stocks
Merck announces Keytruda met the dual primary endpoints in KEYNOTE trial »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

  • 23

    Oct

TIF

Tiffany

$102.26

-0.96 (-0.93%)

06:51
05/23/18
05/23
06:51
05/23/18
06:51
Earnings
Tiffany raises FY18 EPS view to $4.50-$4.70, consensus $4.42 »

Management's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

GDX

Market Vector Gold Miners

$22.12

-0.22 (-0.98%)

06:51
05/23/18
05/23
06:51
05/23/18
06:51
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$122.42

-0.05 (-0.04%)

06:50
05/23/18
05/23
06:50
05/23/18
06:50
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.